NO973421L - Rekombinant DNA omfattende DNA som koder for myosin tungkjede SM1-isoformt protein innskutt i vektor DNA, mikroorganisme som inneholder det rekombinante DNA og et middel for behandling av arteriosklerose omfattende det rekombinante DNA - Google Patents
Rekombinant DNA omfattende DNA som koder for myosin tungkjede SM1-isoformt protein innskutt i vektor DNA, mikroorganisme som inneholder det rekombinante DNA og et middel for behandling av arteriosklerose omfattende det rekombinante DNAInfo
- Publication number
- NO973421L NO973421L NO973421A NO973421A NO973421L NO 973421 L NO973421 L NO 973421L NO 973421 A NO973421 A NO 973421A NO 973421 A NO973421 A NO 973421A NO 973421 L NO973421 L NO 973421L
- Authority
- NO
- Norway
- Prior art keywords
- dna
- recombinant dna
- heavy chain
- recombinant
- myosin heavy
- Prior art date
Links
- 108020004511 Recombinant DNA Proteins 0.000 title abstract 7
- 108020004414 DNA Proteins 0.000 title abstract 4
- 206010003210 Arteriosclerosis Diseases 0.000 title abstract 2
- 102000005604 Myosin Heavy Chains Human genes 0.000 title abstract 2
- 108010084498 Myosin Heavy Chains Proteins 0.000 title abstract 2
- 102000001708 Protein Isoforms Human genes 0.000 title abstract 2
- 108010029485 Protein Isoforms Proteins 0.000 title abstract 2
- 208000011775 arteriosclerosis disease Diseases 0.000 title abstract 2
- 244000005700 microbiome Species 0.000 title abstract 2
- KKJUPNGICOCCDW-UHFFFAOYSA-N 7-N,N-Dimethylamino-1,2,3,4,5-pentathiocyclooctane Chemical compound CN(C)C1CSSSSSC1 KKJUPNGICOCCDW-UHFFFAOYSA-N 0.000 abstract 1
- 238000001415 gene therapy Methods 0.000 abstract 1
- 208000037803 restenosis Diseases 0.000 abstract 1
- 210000002460 smooth muscle Anatomy 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
- C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
- C07K14/4716—Muscle proteins, e.g. myosin, actin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
- C12N1/20—Bacteria; Culture media therefor
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Organic Chemistry (AREA)
- Genetics & Genomics (AREA)
- Zoology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Wood Science & Technology (AREA)
- Biotechnology (AREA)
- Biomedical Technology (AREA)
- Molecular Biology (AREA)
- Biochemistry (AREA)
- Gastroenterology & Hepatology (AREA)
- General Engineering & Computer Science (AREA)
- Biophysics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Toxicology (AREA)
- Microbiology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Heart & Thoracic Surgery (AREA)
- Tropical Medicine & Parasitology (AREA)
- General Chemical & Material Sciences (AREA)
- Physics & Mathematics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Cardiology (AREA)
- Plant Pathology (AREA)
- Vascular Medicine (AREA)
- Urology & Nephrology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Virology (AREA)
- Immunology (AREA)
- Epidemiology (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
Abstract
Det beskrives rekombinant DNA som omfatter DNA som koder for glattmuskel-type myosin tungkjede SM1-isoformt protein innskutt i vektor DNA, en mikroorganisme som bærer den rekombinante DNA og et middel for behandling av arteriosklerose, som omfatter den rekombinante DNA. Denne rekombinante DNA kan benyttes effektivt som et middel ved genterapi ved restenose etter PTCA-behandling.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP1008595 | 1995-01-25 | ||
PCT/JP1996/000134 WO1996023069A1 (fr) | 1995-01-25 | 1996-01-25 | Adn de recombinaison prepare par integration d'adn qui code une proteine isoforme sm1 a chaine lourde de myosine dans un vecteur d'adn, et micro-organisme et remede contre l'arteriosclerose contenant tous deux ledit adn de recombinaison |
Publications (2)
Publication Number | Publication Date |
---|---|
NO973421D0 NO973421D0 (no) | 1997-07-24 |
NO973421L true NO973421L (no) | 1997-09-22 |
Family
ID=11740510
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO973421A NO973421L (no) | 1995-01-25 | 1997-07-24 | Rekombinant DNA omfattende DNA som koder for myosin tungkjede SM1-isoformt protein innskutt i vektor DNA, mikroorganisme som inneholder det rekombinante DNA og et middel for behandling av arteriosklerose omfattende det rekombinante DNA |
Country Status (13)
Country | Link |
---|---|
US (1) | US6593304B1 (no) |
EP (1) | EP0806477B1 (no) |
JP (1) | JP3092944B2 (no) |
KR (1) | KR19980701695A (no) |
AT (1) | ATE236977T1 (no) |
AU (1) | AU711757B2 (no) |
CA (1) | CA2211468A1 (no) |
DE (1) | DE69627307T2 (no) |
FI (1) | FI973104A (no) |
HU (1) | HUP9801762A1 (no) |
NO (1) | NO973421L (no) |
NZ (1) | NZ300270A (no) |
WO (1) | WO1996023069A1 (no) |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH11285333A (ja) * | 1998-02-05 | 1999-10-19 | Vessel Research Laboratory:Kk | 変異型平滑筋ミオシン重鎖遺伝子を有する非ヒト動物の胚幹細胞および非ヒト動物 |
CN1321672A (zh) * | 2000-04-29 | 2001-11-14 | 上海博德基因开发有限公司 | 一种新的多肽——人肌球蛋白重链12-14和编码这种多肽的多核苷酸 |
US6974688B2 (en) * | 2001-08-10 | 2005-12-13 | Cytokinetics, Inc. | Human smooth muscle myosin heavy chain |
US10590452B2 (en) | 2017-12-20 | 2020-03-17 | University Of Seoul Industry Cooperation Foundation | DNA-Mn hybrid particles and method of manufacturing the same |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH0646841A (ja) | 1992-07-24 | 1994-02-22 | Kyowa Hakko Kogyo Co Ltd | トランスフェリン非要求性細胞 |
-
1996
- 1996-01-25 CA CA002211468A patent/CA2211468A1/en not_active Abandoned
- 1996-01-25 WO PCT/JP1996/000134 patent/WO1996023069A1/ja active IP Right Grant
- 1996-01-25 EP EP96901112A patent/EP0806477B1/en not_active Expired - Lifetime
- 1996-01-25 AT AT96901112T patent/ATE236977T1/de not_active IP Right Cessation
- 1996-01-25 JP JP08522776A patent/JP3092944B2/ja not_active Expired - Lifetime
- 1996-01-25 DE DE69627307T patent/DE69627307T2/de not_active Expired - Fee Related
- 1996-01-25 HU HU9801762A patent/HUP9801762A1/hu unknown
- 1996-01-25 US US08/875,435 patent/US6593304B1/en not_active Expired - Fee Related
- 1996-01-25 AU AU44961/96A patent/AU711757B2/en not_active Ceased
- 1996-01-25 NZ NZ300270A patent/NZ300270A/en unknown
- 1996-01-25 KR KR1019970705091A patent/KR19980701695A/ko not_active Application Discontinuation
-
1997
- 1997-07-24 FI FI973104A patent/FI973104A/fi unknown
- 1997-07-24 NO NO973421A patent/NO973421L/no unknown
Also Published As
Publication number | Publication date |
---|---|
EP0806477B1 (en) | 2003-04-09 |
EP0806477A1 (en) | 1997-11-12 |
FI973104A (fi) | 1997-09-24 |
JP3092944B2 (ja) | 2000-09-25 |
FI973104A0 (fi) | 1997-07-24 |
AU711757B2 (en) | 1999-10-21 |
EP0806477A4 (en) | 2000-01-05 |
KR19980701695A (ko) | 1998-06-25 |
NZ300270A (en) | 1998-09-24 |
US6593304B1 (en) | 2003-07-15 |
AU4496196A (en) | 1996-08-14 |
DE69627307D1 (de) | 2003-05-15 |
DE69627307T2 (de) | 2004-03-04 |
HUP9801762A1 (hu) | 1998-11-30 |
NO973421D0 (no) | 1997-07-24 |
ATE236977T1 (de) | 2003-04-15 |
CA2211468A1 (en) | 1996-08-01 |
WO1996023069A1 (fr) | 1996-08-01 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DE69434447D1 (de) | Für die gentherapie verwendbare plasmide | |
DE69738791D1 (de) | Methode zur behandlung von biopolymeren, mikroorganismen oder anderen materialien, die mehr als einen typ von magnetischen partikeln benutzt. | |
NO981353L (no) | Regulerte gener og anvendelser derav | |
TR199802676A2 (xx) | T�m�rlerin, t�m�rle ilgili hastal�klar�n ve ka�eksinin tedavisi ve �nlenmesi i�in y�ntem. | |
NO974824L (no) | Arteriovenöse og venöse transplantasjonsbehandlinger, fremgangsmåter og blandinger | |
HUP9902867A3 (en) | Therapeutic use of vegf protein or nucleic acid coding same and implant, especially for the treatment of intimal hyperplasia | |
AU2001258316A1 (en) | Process for the fermentative preparation of l-threonine | |
AU2002311777A1 (en) | Method of treating arthritis using lentiviral vectors in gene therapy | |
NO910982D0 (no) | Uratoksydase-aktivt protein, rekombinant gen som koder for det, ekspresjonsvektor, mikroorganismer og transformerteceller. | |
DK0687184T3 (da) | Rekombinante adenoviruser og anvendelse deraf ved genterapi til behandling af øjensygdomme | |
DE69721824D1 (de) | Verwendung von carbonanhydrase-hemmern zur behandlung von makulär-ödemen | |
NO973421L (no) | Rekombinant DNA omfattende DNA som koder for myosin tungkjede SM1-isoformt protein innskutt i vektor DNA, mikroorganisme som inneholder det rekombinante DNA og et middel for behandling av arteriosklerose omfattende det rekombinante DNA | |
WO1995027070A1 (de) | Dna-expressionsvektoren zur verwendung in der gentherapeutischen behandlung von gefässerkrankungen | |
DE69733948D1 (de) | In vivo herstellung von replicativen molekülen | |
NO981707L (no) | Xylanase, oligonukleotidsekvens som koder for xylanase og anvendelse derav | |
AU4037299A (en) | Genetically-modified fibroblasts and the use thereof | |
ZA949807B (en) | Regulatory nucleic acid sequences and uses | |
NO985558L (no) | Ny forbedret formulering for behandling av tromboembolisme | |
GB9723824D0 (en) | Cytostatic agents | |
AU2002252443A1 (en) | Method of treating arthritis using lentiviral vectors in gene therapy | |
NZ505580A (en) | Method of treating immunodeficiences using neutrokine alpha | |
EP1185306A4 (en) | USE OF VIRAL VECTORS AND LOADED MOLECULES FOR GENE THERAPY | |
ATE309354T1 (de) | Replikationsprotein-a-bindendes transkriptionsfaktor (rbt1) und dessen verwendungen | |
WO2001037853A3 (en) | Methods and agents for the inhibition of smooth muscle cell proliferation | |
PT1133297E (pt) | Nova aplicacao terapeutica da 1,6-dimetil-8beta-hidroximetil-10alfa-metoxiergolina |